Masato Horikawa

Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

Yuichi Sugiyama, Motohiro Kato, Koji Chiba, 2002, AAPS PharmSci.

The quantitative prediction of in vivo enzyme-induction caused by drug exposure from in vitro information on human hepatocytes.

Yuichi Sugiyama, Motohiro Kato, Koji Chiba, 2005, Drug metabolism and pharmacokinetics.

Interaction of Novel Platelet-Increasing Agent Eltrombopag with Rosuvastatin via Breast Cancer Resistance Protein in Humans

Yukio Kato, Tomoko Sugiura, Yusuke Masuo, 2014, Drug Metabolism and Disposition.